All posts tagged
More News! Allergan sees Patient Deaths, New Alzheimer’s Targets?
French Biotech bids for Crowdfunding in Neurodegenerative Disease
Evotec closes the year partnering with Celgene to treat Alzheimer’s
CRISPR meets RNAi: a whole new Targeted Therapy
Meet the first Biotech to jump on Autophagy after this years’ Nobel Prize
Interviewing the CSO of the newly €90M fund willing to finally tackle Dementia
Sanofi-Genzyme: Still successful 5 years after the acquisition?
Latest Small Molecule against Alzheimer’s Disease Success in Phase I Trials
Hydra’s Immortality is not Myth: Polyps Genetically Reprogram Skin Cells into Neurons
Neurodegenerative Disease in the UK: Takeda, NIHR & UCL Research Collaboration
Spanish connection: VC leads Biotech series A Fund to cure Rare Neurodegenerative Disease
TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough
Labiotech UG, All Rights Reserved -
Send this to friend